Journal of Voice
Volume 24, Issue 4 , Pages 477-489 , July 2010

Beta-Adrenergic Blockade and Voice: A Double-Blind, Placebo-Controlled Trial

Preliminary findings from this research were presented orally at: Collier Giddens, C. (2001). Physiologic Voice Measures Following Beta-Adrenergic Blockade. Paper presented at the American Speech-Language-Hearing Association National Convention, New Orleans, LA.

  • Cheryl L. Giddens

      Affiliations

    • Communication Sciences & Disorders, Oklahoma State University, Stillwater, Oklahoma
    • Corresponding Author InformationAddress correspondence and reprint requests to Cheryl L. Giddens, Communication Sciences & Disorders, 110, Hanner, Stillwater, OK 74078-5062.
    • ,
  • Kirk W. Barron

      Affiliations

    • University of North Texas Health Sciences Center in Fort Worth, Physician Assistant Studies, Fort Worth, Texas
    • ,
  • Keith F. Clark

      Affiliations

    • Saint Anthony Hospital, Department of Otolaryngology, Oklahoma City, Oklahoma
    • ,
  • William D. Warde

      Affiliations

    • Department of Statistics, Oklahoma State University, Stillwater, Oklahoma

,Accepted 2 December 2008.

References 

  1. Kenny DT, Davis P, Oates J. Music performance anxiety and occupational stress amongst opera chorus artists and their relationship with state and trait anxiety and perfectionism. J Anxiety Disord. 2004;18:757–777
  2. Lehrer P, Goldman N, Strommen E. A principal components assessment of performance anxiety among musicians. Med Prob Perform Artists. 1990;5:12–18
  3. Sternbach DJ. Musicians: a neglected working population in crisis. In:  Sauter S,  Murphy L editor. Organizational Risk Factors for Job Stress. Washington, D.C.: American Psychological Association; 1995;p. 283–302xii, 400
  4. Gates G, Saegert J, Wilson N, Johnson L, Shepherd A, Hearne E. Effect of beta blockade on singing performance. Ann Otol Rhinol Laryngol. 1985;94:570–574
  5. Fishbein M, Middlestadt S. The ICSOM Medical Questionnaire: medical problems among ICSOM musicians: overview of a national survey. Senza Sordino. 1987;25:1–8
  6. Cirigliano M, Lynn L. Diagnosis and treatment of stage fright. Hosp Pract. 1992;27:58–62
  7. Gates G, Montalbo P. The effect of low-dose beta-adrenergic blockade on performance anxiety in singers. J Voice. 1987;1:105–108
  8. Johannes B, Wittels P, Enne R, et al. Non-linear function model of voice pitch dependency on physical and mental load. Eur J Appl Physiol. 2007;101:267–276
  9. Mendoza E, Carballo G. Acoustic analysis of induced vocal stress by means of cognitive workload tasks. J Voice. 1998;12:263–273
  10. van den Broek EL. Emotional prosody measurement (EPM): a voice-based evaluation method for psychological therapy effectiveness. Stud Health Technol Inf. 2004;103:118–125
  11. Wittels P, Johannes B, Enne R, Kirsch K, Gunga H. Voice monitoring to measure emotional load during short-term stress. Eur J Appl Physiol. 2002;87:278–282
  12. Griffin GR, Williams CE. The effects of different levels of task complexity on three vocal measures. Aviat Space Environ Med. 1987;58:1165–1170
  13. Rubenstein L. Electro-acoustical measurement of vocal responses to limited stress. Behav Res Ther. 1966;4:135–141
  14. Streeter LA, Macdonald NH, Apple W, Krauss RM, Galotti KM. Acoustic and perceptual indicators of emotional stress. J Acoust Soc Am. 1983;73:1354–1360
  15. Kenny DT. A systematic review of treatments for music performance anxiety. Anxiety Stress Coping. 2005;18:183–205
  16. Brantigan C, Brantigan T, Joseph N. Effect of beta blockade and beta stimulation on stage fright. Am J Med. 1982;72:88–94
  17. Clark D, Agras W. The assessment and treatment of performance anxiety in musicians. Am J Psychiatry. 1992;148:598–605
  18. Hartley L, Ungapen S, Davie I, Spencer D. The effect of beta adrenergic blocking drugs on speakers' performance and memory. Br J Psychiatry. 1983;142:512–517
  19. James I, Pearson R, Griffith D, Newbury P. Effect of oxprenolol on stage-fright in musicians. Lancet. 1977;2:952–954
  20. Liden S, Gottfries CG. Beta-blocking agents in the treatment of catecholamine-induced symptoms in musicians. Lancet. 1974;2:529
  21. Huffman JC, Stern TA. Neuropsychiatric consequences of cardiovascular medications. Dialogues Clin Neurosci. 2007;9:29–45
  22. Pierangeli G, Cevoli S, Grimaldi D, Zanigni S, Montagna P, Cortelli P. Which therapy for which patient?. Neurol Sci. 2006;27:S153–S158
  23. Walsh N, Schoenfeld L, Ramamurthy S, Hoffman J. Normative model for cold pressor test. Am J Phys Med Rehab. 1989;68:6–11
  24. Wenger MA, Clemens TL, Cullen TD. Autonomic functions in patients with gastrointestinal and dermatological disorders. Psychosom Med. 1962;24:267–273
  25. Kiriyama A, Honbo A, Iga K. Analysis of hepatic metabolism affecting pharmacokinetics of propranolol in humans. Int J Pharm. 2007;349:53–60
  26. Kopitar Z, Vrhova B, Lenardic A, Cvelbar P, Zorz M, Francetic I. Dose-dependent bioavailability of propranolol. Int J Clin Pharmacol Ther Toxicol. 1986;24:319–322
  27. Ryalls J, Zipprer A, Baldauff P. A preliminary investigation of the effects of gender and race on voice onset time. J Speech Lang Hear Res. 1997;40:642–645
  28. Schiavetti N, Whitehead RL, Metz DE, Whitehead B, Mignerey M. Voice onset time in speech produced during simultaneous communication. J Speech Hear Res. 1996;39:565–572
  29. Deliyski D. Acoustic model and evaluation of pathological voice production. Proceedings of the 3rd Conference on Speech Communication and Technology. Berlin, Germany: EUROSPEECH'93; 1993;
  30. Scherer R. Laryngeal function during phonation. Natl Center Voice Speech Status Prog Rep. 1994;7:171
  31. Wolfe V, Fitch J, Cornell R. Acoustic prediction of severity in commonly occurring voice problems. J Speech Hear Res. 1995;38:273–279
  32. Holmberg E, Hillman R, Perkell J. Glottal airflow and transglottal air pressure measurements for male and female speakers in soft, normal, and loud voice. J Acoust Soc Am. 1988;84:511–529
  33. Holmberg EB, Hillman RE, Perkell JS. Glottal airflow and transglottal air pressure measurements for male and female speakers in low, normal, and high pitch. J Voice. 1989;3:294–305
  34. Rothenberg M. A new inverse-filtering technique for deriving the glottal air flow waveform during voicing. J Acoust Soc Am. 1973;53:1632–1645
  35. Holmberg EB, Hillman RE, Perkell JS, Gress C. Relationships between intra-speaker variation in aerodynamic measures of voice production and variation in SPL across repeated recordings. J Speech Hear Res. 1994;37:484–495
  36. Holmberg EB, Hillman RE, Perkell JS, Guiod PC, Goldman SL. Comparisons among aerodynamic, electroglottographic, and acoustic spectral measures of female voice. J Speech Hear Res. 1995;38:1212–1223
  37. Orlikoff R, Baken R. The effect of the heartbeat on vocal fundamental frequency perturbation. J Speech Hear Res. 1989;32:576–582
  38. Orlikoff R. Vowel amplitude variation associated with the heart cycle. J Acoust Soc Am. 1990;88:2091–2098
  39. Eden G, Inbar GF. Physiological model analysis of involuntary human-voice tremor. Biol Cybern. 1978;30:179–185
  40. Hoit JD, Solomon MP, Hixon TH. Effect of lung volume on voice onset time (VOT). J Speech Hear Res. 1993;36:516–520
  41. Brenner M, Doherty ET, Shipp T. Speech measures indicating workload demand. Aviat Space Environ Med. 1994;65:21–26
  42. Kuroda I, Fujiwara O, Okamura N, Utsuki N. Method for determining pilot stress through analysis of voice communication. Aviat Space Environ Med. 1976;47:528–533
  43. Simonov PV, Frolov MV. Analysis of the human voice as a method of controlling emotional state: achievements and goals. Aviat Space Environ Med. 1977;48:23–25
  44. Girdler SS, Hinderliter AL, Light KC. Peripheral adrenergic receptor contributions to cardiovascular reactivity: influence of race and gender. J Psychosom Res. 1993;37:177–193
  45. Hastrup JL, Light KC. Sex differences in cardiovascular stress responses: modulation as a function of menstrual cycle phases. J Psychosom Res. 1984;28:475–483
  46. McLean JK, Sathasivam P, MacNaughton K, Graham TE. Cardiovascular and norepinephrine responses of men and women to two cold pressor tests. Can J Physiol Pharmacol. 1992;70:36–42
  47. Tersman Z, Collins A, Eneroth P. Cardiovascular responses to psychological and physiological stressors during the menstrual cycle. Psychosom Med. 1991;53:185–197
  48. Tucker DC, Bhatnaga RK, Johnson AK. Genetic and environmental influences on developing autonomic control of heart rate. Am J Physiol. 1984;246(4 Pt 2):R578–R586
  49. Kolk AM, van Well S. Cardiovascular responses across stressor phases: the match of gender and gender-role identification with the gender relevance of the stressor. J Psychosom Res. 2007;62:197–205
  50. McLean JK, Sathasivam P, MacNaughton K, Graham TE. Cardiovascular and norepinephrine responses of men and women to two cold pressor tests. Biol Cybern. 1992;70:36–42
  51. Willemsen G, Carroll D, Ring C, Drayson M. Cellular and mucosal immune reactions to mental and cold stress: associations with gender and cardiovascular reactivity. Psychophysiology. 2002;39:222–228
  52. Pollard C, Henderson J. Four types of social phobia in a community sample. J Nerv Ment Dis. 1988;176:440–445
  53. Schneider RH, Julius S, Moss GE, Dielman TE, Zweifler AJ, Karunas R. New markers for type A behavior: pupil size and platelet epinephrine. Psychosom Med. 1987;49:579–590
  54. Brunton LL, Lazo JS, Parker KL. Goodman and Gilman's the Pharmacological Basis of Therapeutics. 11th ed.. Los Angeles: The McGraw Hill Co.; 2006;

PII: S0892-1997(08)00206-3

doi: 10.1016/j.jvoice.2008.12.002

Journal of Voice
Volume 24, Issue 4 , Pages 477-489 , July 2010

Article Tools

* Image Usage & Resolution